JPWO2021004214A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021004214A5 JPWO2021004214A5 JP2022501337A JP2022501337A JPWO2021004214A5 JP WO2021004214 A5 JPWO2021004214 A5 JP WO2021004214A5 JP 2022501337 A JP2022501337 A JP 2022501337A JP 2022501337 A JP2022501337 A JP 2022501337A JP WO2021004214 A5 JPWO2021004214 A5 JP WO2021004214A5
- Authority
- JP
- Japan
- Prior art keywords
- detection
- seq
- methylation
- col4a1
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910624566.4 | 2019-07-11 | ||
| CN201910624566.4A CN110317871B (zh) | 2019-07-11 | 2019-07-11 | 一种基因标志物组合及其应用 |
| PCT/CN2020/094954 WO2021004214A1 (zh) | 2019-07-11 | 2020-06-08 | 一种基因标志物组合及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022539904A JP2022539904A (ja) | 2022-09-13 |
| JPWO2021004214A5 true JPWO2021004214A5 (zh) | 2023-07-25 |
Family
ID=68121995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022501337A Pending JP2022539904A (ja) | 2019-07-11 | 2020-06-08 | 遺伝子マーカー組成物及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220259672A1 (zh) |
| EP (1) | EP3998354A4 (zh) |
| JP (1) | JP2022539904A (zh) |
| KR (1) | KR20220032603A (zh) |
| CN (1) | CN110317871B (zh) |
| AU (1) | AU2020310247B2 (zh) |
| CA (1) | CA3146980A1 (zh) |
| TW (1) | TWI736036B (zh) |
| WO (1) | WO2021004214A1 (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110331142B (zh) * | 2019-07-11 | 2021-12-21 | 广州康立明生物科技股份有限公司 | 一种多基因联合检测试剂 |
| CN110317871B (zh) * | 2019-07-11 | 2022-06-07 | 广州康立明生物科技股份有限公司 | 一种基因标志物组合及其应用 |
| CN110699437B (zh) * | 2019-11-11 | 2023-06-20 | 益善生物技术股份有限公司 | 人sdc2基因甲基化检测试剂盒 |
| BR112023021409A2 (pt) * | 2021-04-23 | 2023-12-19 | Bgi Genomics Co Ltd | Composição, kit e aplicação para detecção de câncer coloretal |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60232059D1 (de) * | 2001-03-01 | 2009-06-04 | Epigenomics Ag | Verfahren zur entwicklung von gensätzen zu diagnostischen und therapeutischen zwecken auf grundlage des expressions- und methylierungsstatus der gene |
| US20070099209A1 (en) * | 2005-06-13 | 2007-05-03 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| WO2010045463A2 (en) * | 2008-10-15 | 2010-04-22 | Government Of The United States As Represented By The Secretary Of The Army | Clinical decision model |
| EP2507397A4 (en) * | 2009-12-01 | 2013-05-01 | Compendia Bioscience Inc | CLASSIFICATION OF CANCERS |
| WO2012034170A1 (en) * | 2010-09-13 | 2012-03-22 | Clinical Genomics Pty. Ltd | Epigenetic markers of colorectal cancers and diagnostic methods using the same |
| US10166210B2 (en) * | 2014-06-12 | 2019-01-01 | Nsabp Foundation, Inc. | Methods of subtyping CRC and their association with treatment of colon cancer patients with oxaliplatin |
| CN105543354B (zh) * | 2015-12-31 | 2019-07-26 | 广州市康立明生物科技有限责任公司 | 一种肿瘤分子检测/诊断试剂 |
| CN106947822B (zh) * | 2017-04-12 | 2020-04-10 | 广州市康立明生物科技有限责任公司 | Itga4基因甲基化检测试剂、试剂盒及检测方法 |
| CN108977543B (zh) * | 2018-08-06 | 2021-12-14 | 上海锐翌生物科技有限公司 | 一种基于联合检测sdc2和sfrp2基因甲基化水平的结直肠癌早期诊断试剂 |
| CN109207592B (zh) | 2018-09-26 | 2020-01-10 | 人和未来生物科技（长沙）有限公司 | 用于结直肠癌检测的试剂盒及其应用 |
| CN110317871B (zh) * | 2019-07-11 | 2022-06-07 | 广州康立明生物科技股份有限公司 | 一种基因标志物组合及其应用 |
-
2019
- 2019-07-11 CN CN201910624566.4A patent/CN110317871B/zh active Active
- 2019-11-26 TW TW108142907A patent/TWI736036B/zh active
-
2020
- 2020-06-08 EP EP20837012.2A patent/EP3998354A4/en active Pending
- 2020-06-08 AU AU2020310247A patent/AU2020310247B2/en active Active
- 2020-06-08 CA CA3146980A patent/CA3146980A1/en active Pending
- 2020-06-08 WO PCT/CN2020/094954 patent/WO2021004214A1/zh unknown
- 2020-06-08 US US17/626,038 patent/US20220259672A1/en active Pending
- 2020-06-08 KR KR1020227004560A patent/KR20220032603A/ko unknown
- 2020-06-08 JP JP2022501337A patent/JP2022539904A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI741418B (zh) | 多基因聯合檢測試劑 | |
| TWI736036B (zh) | 一種基因標記組合及其用途 | |
| TWI775168B (zh) | 基因標記組合及其應用 | |
| US20220307091A1 (en) | Unbiased dna methylation markers define an extensive field defect in histologically normal prostate tissues associated with prostate cancer: new biomarkers for men with prostate cancer | |
| TWI730429B (zh) | Hoxa7甲基化檢測試劑 | |
| US20120135877A1 (en) | DNA Methylation Markers For Prostate Cancer Field Defect | |
| JP7133039B2 (ja) | 腫瘍マーカー、メチル化検出試薬、キット及びその使用 | |
| TW202028473A (zh) | Hoxa9甲基化檢測試劑在製備肺癌診斷試劑中的用途 | |
| JP7123177B2 (ja) | 腫瘍マーカー、メチル化検出試薬、キット及びその使用 | |
| TWI774992B (zh) | Hoxa7甲基化檢測試劑在製備肺癌診斷試劑中的用途 | |
| TWI716883B (zh) | 腫瘤標誌物、甲基化檢測試劑、試劑盒及其應用 | |
| JPWO2021004214A5 (zh) | ||
| EP2978861B1 (en) | Unbiased dna methylation markers define an extensive field defect in histologically normal prostate tissues associated with prostate cancer: new biomarkers for men with prostate cancer | |
| WO2019223519A1 (zh) | 肿瘤标志物、甲基化检测试剂、试剂盒及其应用 | |
| KR20210083100A (ko) | 대장암환자의 rcc 또는 lcc 판별용 마커 | |
| TWI730327B (zh) | 腫瘤標誌物、甲基化檢測試劑、試劑盒及其應用 | |
| RU2824399C1 (ru) | Комбинация генных маркеров и их применение | |
| CN114150065B (zh) | 一种结直肠癌或癌前病变的标记物及其应用 | |
| RU2775177C1 (ru) | Опухолевый маркер, реагент для выявления метилирования, набор и их применение | |
| WO2019223520A1 (zh) | 肿瘤标志物、甲基化检测试剂、试剂盒及其应用 |